Holen Sie sich die Stockscreener-App
149.28
1.36%
-1.9953
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$151.28
Offen:
$150.5
24-Stunden-Volumen:
35,210
Relative Volume:
0.03
Marktkapitalisierung:
$9.95B
Einnahmen:
$12.82B
Nettoeinkommen (Verlust:
$936.34M
KGV:
13.90
EPS:
10.74
Netto-Cashflow:
$1.47B
1W Leistung:
-0.79%
1M Leistung:
+38.01%
6M Leistung:
+6.31%
1J Leistung:
+5.05%
1-Tages-Spanne:
$148.63
$151.11
1-Wochen-Bereich:
$146.08
$154.50
52-Wochen-Spanne:
$101.00
$157.12
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, UHS, FMS, ENSG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
148.83 | 10.11B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
524.13 | 119.85B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
233.85 | 20.33B | 20.69B | 2.40B | 1.55B | 15.62 |
|
UHS
Universal Health Services Inc
|
230.48 | 14.53B | 16.08B | 1.20B | 1.06B | 17.82 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.92 | 14.25B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
212.13 | 12.45B | 4.11B | 239.98M | 193.10M | 4.12 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
Will DaVita’s (DVA) US$5.6 Billion Buybacks and Tech Push Change Its Capital Allocation Narrative - simplywall.st
DaVita Inc. (DVA) Stock Analysis: Navigating the Healthcare Sector with a Strong Return on Equity - DirectorsTalk Interviews
Is DaVita (DVA) Stock Undervalued Right Now? - Yahoo Finance
Is It Too Late To Consider DaVita (DVA) After Its Sharp 30 Day Surge - Yahoo Finance
DaVita Inc. (DVA): A Bull Case Theory - MSN
Layoff Watch: Can DaVita Inc continue delivering strong returnsJuly 2025 Rallies & Expert-Curated Trade Recommendations - baoquankhu1.vn
Wall Street Zen Upgrades DaVita (NYSE:DVA) to Buy - MarketBeat
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term - Yahoo Finance
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $2.56 Million Stock Holdings in DaVita Inc. $DVA - Defense World
Zacks.com featured highlights include DaVita, Ford, Centerra, Southwest Airlines and Patria Investments - Yahoo Finance
October 16th Options Now Available For DaVita (DVA) - Nasdaq
DaVita Stock Is Up 35% Since February. Here’s Where Shares Could Go in 2026 - TIKR.com
Skandinaviska Enskilda Banken AB publ Reduces Stock Position in DaVita Inc. $DVA - MarketBeat
Berkshire’s New CEO Just Offloaded DaVita Stocks: Should You Sell Yours Too? - AOL.com
Berkshire's New CEO Just Offloaded DaVita Stocks: Should You Sell Yours Too? - GOBankingRates
A | Will DaVita Inc. stock benefit from M&A2025 Market Overview & Weekly High Return Stock Forecasts - mfd.ru
Todd Asset Management LLC Makes New Investment in DaVita Inc. $DVA - MarketBeat
DaVita Inc. (DVA) Stock Analysis: A Healthcare Giant with a Robust ROE and a Modest Upside - DirectorsTalk Interviews
National Donor Day Spotlight: DaVita Patient Care Technician Donates Kidney - ACCESS Newswire
DaVita Inc. $DVA Shares Sold by Principal Financial Group Inc. - MarketBeat
Why DaVita (DVA) Is Up 5.8% After Massive Buybacks Amid Softer EarningsAnd What's Next - simplywall.st
Can DaVita Stock Hold Up When Markets Turn? - Trefis
National Donor Day Spotlight: DaVita Patient Care Technician Don - GuruFocus
What are DaVita Inc.’s technical support levelsJuly 2025 Closing Moves & Safe Capital Growth Plans - mfd.ru
LSV Asset Management Sells 13,700 Shares of DaVita Inc. $DVA - MarketBeat
Can DaVita Inc. continue delivering strong returnsPortfolio Value Summary & Verified Short-Term Plans - mfd.ru
AlphaQuest LLC Sells 12,031 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Kidney Care Profit Milestone Highlights Emerging Value Based Earnings Mix - Yahoo Finance
The Dialysis Renaissance: How DaVita (DVA) Conquered the GLP-1 Fear and Defined Healthcare Resilience in 2026 - The Chronicle-Journal
Can DaVita Inc. stock double in next 5 yearsWeekly Investment Recap & Accurate Entry/Exit Alerts - mfd.ru
DaVita Inc (DVA) Stock Price Up 3.19% on Feb 11 - GuruFocus
Gains Report: Will DaVita Inc benefit from seasonalityJuly 2025 PostEarnings & Long-Term Capital Growth Strategies - baoquankhu1.vn
Palmetto Grain Brokerage - Palmetto Grain Brokerage
DaVita Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
The 5 Most Interesting Analyst Questions From DaVita’s Q4 Earnings Call - Yahoo Finance
2 Warren Buffett Stocks to Buy Hand Over Fist in 2026 and 1 to Avoid - The Motley Fool
DaVita Dipped 6% After Big Run-Up: Why Analysts See a Path to $210 in 2026 - TIKR.com
DaVita (DVA) Surges as Top Healthcare Gainer in S&P 500 - GuruFocus
DaVita (DVA) Is Up 28.8% After Strong 2026 Guidance And Heavy BuybacksWhat's Changed - simplywall.st
Guidance Update: Will DaVita Inc stock benefit from M AMarket Risk Report & Weekly Chart Analysis and Guides - baoquankhu1.vn
DaVita Inc. $DVA Shares Sold by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
DaVita, Elara deal could signal new take on kidney, home care - Modern Healthcare News
DaVita Inc.’s Quiet Advantage—Why Better Patient Outcomes Could Mean Better Economics! - Smartkarma
DaVita (NYSE:DVA) Shares Down 4.5%Time to Sell? - MarketBeat
DaVita (NYSE:DVA) Upgraded by Zacks Research to "Strong-Buy" Rating - MarketBeat
Even With A 30% Surge, Cautious Investors Are Not Rewarding DaVita Inc.'s (NYSE:DVA) Performance Completely - simplywall.st
DaVita Inc. $DVA Shares Sold by Allianz Asset Management GmbH - MarketBeat
Analysts Offer Insights on Healthcare Companies: DaVita (DVA) and Immunocore Holdings (IMCR) - The Globe and Mail
Should Value Investors Buy DaVita (DVA) Stock? - Yahoo Finance
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term - Yahoo Finance
DaVita Inc. (NYSE:DVA) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):